January 21, 2025
Adobe

Opinion: Final sale: my eight-year struggle to return recalled breast implants

After a voluntary double mastectomy to lower cancer risk, I learned that my breast implants put me at risk of lymphoma — and no one would remove them.

By Oceana Callum


STAT+ | AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug

The drug, to be marketed as Datroway and known as Dato-DXd, is also in testing for different forms of breast and lung cancers.

By Andrew Joseph


Trump’s initial orders reverse Biden on health care costs, protections from discrimination

Trump's executive orders took aim at Biden's priorities, from drug pricing to gender discrimination.

By Sarah Owermohle, John Wilkerson, Rachel Cohrs Zhang, and Lizzy Lawrence



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.